Top

International Journal of Colorectal Disease

Published in:

01-07-2004 | Original Article

Questions on life satisfaction (FLZ^M) in inflammatory bowel disease

Authors: K.-H. Janke, A. Raible, M. Bauer, P. Clemens, C. Meisner, W. Häuser, U. Steder-Neukamm, G. Henrich, P. Herschbach, M. Gregor, B. Klump

Published in: International Journal of Colorectal Disease | Issue 4/2004

Abstract

Background and aims

When assessing quality of care the outcome in terms of quality of life (QOL) is of major significance. This study examined QOL in IBD outpatients and the contribution of individual expectations and various other factors including disease activity.

Patients and methods

The study included 306 outpatients with Crohn’s disease and 109 with ulcerative colitis (UC). General and health-related QOL was quantified using the instrument Questions on Life Satisfaction^Modules. Disease activity was assessed by a questionnaire. Data were compared with a normal population sample.

Results

Life satisfaction scores on general items and on health-related items were significantly lower than in a control sample (60.5±37.3 and 74.4±41.5, respectively) among both CD patients (54.3±33.2, 59.1±38.8) and UC patients (45.4±34.0, 52.1±40.7). Scores were significantly related to severity of disease activity. IBD patients attributed particular importance to health-related issues.

Conclusion

Both health-related and general life satisfaction is compromised in IBD outpatients, and health-related topics have major impact. Not surprisingly, inflammatory activity compromises QOL, which underlines the importance of anti-inflammatory strategies. The importance attributed to health-related features is higher in IBD patients than in the normal population.

Schmidt C, Reibe F, Güntert B, Küchler T, Henne-Bruns D (1999) Quality of life as an outcome parameter in medicine. Gesundh Okon Qual Manage 4:85–91

Häuser W, Grandt D (2001) Quality of life measurement in gastroenterology—concepts, instruments and problems. Z Gastroenterol 39:475–481CrossRefPubMed

Fölsch UR, Oertel WH, Rausch C, Hirsch MC, Jaeger TM (2002) Kompetenznetze in der Medizin: eine Standortbestimmung. Dtsch Arztebl 7:335–337

Drossmann DA (1996) Inflammatory bowel disease. In: Spilker B (eds) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, Philadelphia, pp 925–935

Henrich G, Herschbach P (2000) Questions on life satisfaction (FLZ^M)—a short questionnaire for assessing subjective quality of life. Eur J Psychol Assess 16:150–159CrossRef

Henrich G, Herschbach P (2000) Fragen zur Lebenszufriedenheit (FLZ^M). In: Ravens-Sieberer U, Cieza A (eds) Lebensqualitätsforschung und Gesundheitsökonomie in der Medizin. ecomed, Landsberg, pp 98–110

Best WR, Becktel JM, Singelton JW, Kern F (1976) Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444

Kjeldsen J, Schafalitzky de Muckadell OB (1993) Review—assessment of disease severity and activity in inflammatory bowel disease. Scand J Gastroenterol 28:1–9PubMed

Harvey RF, Bradshaw JM (1980) A simple index of Crohn’s disease activity. Lancet 1:514

10.

Myren J, Bouchier IAD, Watkinson G, Sofley A, Clamp SE, de Dombal FT (1984) The O.M.G.E. multinational inflammatory bowel disease survey 1976–1982. A further report on 2,657 cases. Scand J Gastroenterol 19 [Suppl 95]:1–27

11.

WHO (1995) Technical report series no. 854. WHO, Geneva (http://www.chd-taskforce.de/guidelines/kap22.htm

12.

Rachmilewitz D (1989) Coated mesalazine (5-amino-salicylic acid) versus sulpasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 198:82–86

13.

Love JR, Irvine EJ, Fedorak N (1992) Quality of life in inflammatory bowel disease. J Clin Gastroenterol 14:15–19PubMed

14.

Han SW, McColl E, Steen N et al (1998) The inflammatory bowel disease questionnaire: a valid and reliable measure in ulcerative colitis patients in the north east of England. Scand J Gastroenterol 33:961–966CrossRefPubMed

15.

Boer AGEM de et al (1995) Inflammatory bowel disease questionnaire: cross-cultural adaption and further validation. Eur J Gastroenterol Hepatol 7:1043–1050PubMed

16.

Ipsen D (1978) The construct satisfaction. Soziale Welt 29:44–53

17.

Dür W, Grossmann W, Schmied H (2000) Patientenzufriedenheit und Patientenerwartung im Krankenhaus. Statistische Analysen als Hilfsmittel im Benchmarking. In: Bullinger M, Siegrist J, Ravens-Sieberer U (eds) Lebensqualitätsforschung in medizinpsychologischer und -soziologischer Perspektive. Hogrefe, Jahrbuch medizinische Psychologie 18:222–243

18.

Williams B (1994) Patient satisfaction: a valid concept? Soc Sci Med 38:509–516CrossRefPubMed

19.

Aharony L, Strasser S (1993) Patient satisfaction: what we know about and what we still need to explore. Med Care Rev 50:49–79PubMed

20.

Herschbach P (2002) The “well-being paradox” in quality-of-life research. On what does our sense of well-being depend? Psychother Psychol Med 52:141–150CrossRef

21.

Snaith P, Zigmont AS (1995) Hospital anxiety and depression scale: HADS-D. Deutsche Version: Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin; Testdokumentation und Handanweisung, 1st edn. Herrmann C, Buss U (eds) Huber, Bern

22.

Deutsche Arbeitsgemeinschaft Epidemiologie (DAE), Arbeitsgruppe Epidemiologische Methoden (1999) Messung und Quantifizierung soziographischer Merkmale in epidemiologischen Studien. Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS), Deutsche Gesellschaft für Sozialmedizin und Prävention (DGSMP), Deutsche Region der Internationalen Biometrischen Gesellschaft (DR-IBS) (eds) (http://medweb.uni-muenster.de/institute/epi/dae/)

23.

Lopez-Vivancos, Casellas F, Badia X et al (1999) Validation of the Spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn’s disease. Digestion 60:274–280CrossRefPubMed

24.

Love JR, Irvine EJ, Fedorak N (1992) Quality of life in inflammatory bowel disease. J Clin Gastroenterol 14:15–19PubMed

25.

Mitchell A, Guyatt G, Singer J, Irvine EJ (1988) Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 10:306–310

26.

Russel MGVM et al (1997) Validation of the Dutch translation of the inflammatory bowel disease questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion 58:282–288PubMed

27.

Kim WH et al (1999) Quality of life in Koreans patients with inflammatory bowel diseases: ulcerative colitis, Crohn’s disease and intestinal Behcet’s disease. Int J Colorectal Dis 14:52–57

28.

Pukrop R, Möller HJ, Saß H et al (1999) Quality of life. A contribution to construct validation and the development of a modular system. Nervenarzt 70:41–53CrossRefPubMed

Title: Questions on life satisfaction (FLZM) in inflammatory bowel disease
Authors: K.-H. Janke
A. Raible
M. Bauer
P. Clemens
C. Meisner
W. Häuser
U. Steder-Neukamm
G. Henrich
P. Herschbach
M. Gregor
B. Klump
Publication date: 01-07-2004
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 4/2004
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-003-0522-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Questions on life satisfaction (FLZ^M) in inflammatory bowel disease

Abstract

Background and aims

Patients and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and aims

Patients and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2004

Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn’s disease

Simplified placement and management of cutting setons in the treatment of transsphincteric anal fistula: technical note

Open versus closed day-case haemorrhoidectomy: is there any difference?

Balloon tamponade to control haemorrhage following transanal rectal surgery

Optimising the diagnostic value of Anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn’s disease

Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations